132 related articles for article (PubMed ID: 34147517)
61. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
62. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
Bellur Atici E; Karlığa B
J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
[TBL] [Abstract][Full Text] [Related]
63. Design, development, and characterization of amorphous rosuvastatin calcium tablets.
González R; Peña MÁ; Torres NS; Torrado G
PLoS One; 2022; 17(3):e0265263. PubMed ID: 35312730
[TBL] [Abstract][Full Text] [Related]
64. Transformations between Co-Amorphous and Co-Crystal Systems and Their Influence on the Formation and Physical Stability of Co-Amorphous Systems.
Wu W; Wang Y; Löbmann K; Grohganz H; Rades T
Mol Pharm; 2019 Mar; 16(3):1294-1304. PubMed ID: 30624075
[TBL] [Abstract][Full Text] [Related]
65. Formulation development and in vitro evaluation of solidified self-microemulsion in the form of tablet containing atorvastatin calcium.
Ali KA; Mukherjee B; Bandyopadhyay AK
Drug Dev Ind Pharm; 2013 Nov; 39(11):1742-9. PubMed ID: 23216220
[TBL] [Abstract][Full Text] [Related]
66. A three-layer guar gum matrix tablet for oral controlled delivery of highly soluble metoprolol tartrate.
Krishnaiah YS; Karthikeyan RS; Satyanarayana V
Int J Pharm; 2002 Jul; 241(2):353-66. PubMed ID: 12100863
[TBL] [Abstract][Full Text] [Related]
67. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
Pandey S; Patil AT
Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
[TBL] [Abstract][Full Text] [Related]
68. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets.
Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
Pharm Dev Technol; 2018 Jun; 23(5):454-463. PubMed ID: 27681386
[TBL] [Abstract][Full Text] [Related]
69. Co-amorphous palbociclib-organic acid systems with increased dissolution rate, enhanced physical stability and equivalent biosafety.
Zhang M; Xiong X; Suo Z; Hou Q; Gan N; Tang P; Ding X; Li H
RSC Adv; 2019 Jan; 9(7):3946-3955. PubMed ID: 35518078
[TBL] [Abstract][Full Text] [Related]
70. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
71. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
72. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
[TBL] [Abstract][Full Text] [Related]
73. Detrimental Effect of the Film Coat Chemistry and Thickness on the Physical Stability of Amorphous Solid Dispersions in Tablet Formulations.
Punia A; Biyyala V; Faassen F; Ash J; Lamm MS
J Pharm Sci; 2023 Mar; 112(3):708-717. PubMed ID: 36189478
[TBL] [Abstract][Full Text] [Related]
74. Dissolution of ibuprofen enantiomers from coprecipitates and suspensions containing chiral excipients.
Janjikhel RK; Adeyeye CM
Pharm Dev Technol; 1999 Jan; 4(1):9-17. PubMed ID: 10027208
[TBL] [Abstract][Full Text] [Related]
75. Investigation of the formation of drug-drug cocrystals and coamorphous systems of the antidiabetic drug gliclazide.
Aljohani M; MacFhionnghaile P; McArdle P; Erxleben A
Int J Pharm; 2019 Apr; 561():35-42. PubMed ID: 30802549
[TBL] [Abstract][Full Text] [Related]
76. Lubricant-Induced Crystallization of Itraconazole From Tablets Made of Electrospun Amorphous Solid Dispersion.
Démuth B; Farkas A; Balogh A; Bartosiewicz K; Kállai-Szabó B; Bertels J; Vigh T; Mensch J; Verreck G; Van Assche I; Marosi G; Nagy ZK
J Pharm Sci; 2016 Sep; 105(9):2982-2988. PubMed ID: 27290626
[TBL] [Abstract][Full Text] [Related]
77. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
[TBL] [Abstract][Full Text] [Related]
78. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Sun W; Ni R; Zhang X; Li LC; Mao S
Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
[TBL] [Abstract][Full Text] [Related]
79. Characterization of excipient and tableting factors that influence folic acid dissolution, friability, and breaking strength of oil- and water-soluble multivitamin with minerals tablets.
Du J; Hoag SW
Drug Dev Ind Pharm; 2003 Nov; 29(10):1137-47. PubMed ID: 14677774
[TBL] [Abstract][Full Text] [Related]
80. Optimization and Advantages of Molded Tablets Using Trehalose as a Binder.
Takahashi Y; Furuishi T; Yonemochi E
Chem Pharm Bull (Tokyo); 2023; 71(6):416-423. PubMed ID: 37258194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
